Literature DB >> 18765955

Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.

Yu Bai1, Jun Gao, Xingang Shi, Duowu Zou, Zhaoshen Li.   

Abstract

BACKGROUND: Data regarding the use of corticosteroids for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis are conflicting. The aim of this meta-analysis was to compare corticosteroids with placebo for prevention of post-ERCP pancreatitis.
METHODS: Multiple databases including MEDLINE, EMBASE, Cochrane controlled trials register, the Cochrane Library, Science Citation Index, Google Scholar and Google updated to June 2007 were searched to retrieve the relevant randomized controlled trials. Primary outcome measure was post-ERCP pancreatitis.
RESULTS: Six randomized controlled trials involving 2,448 patients were identified. The analysis showed that corticosteroids did not prevent post-ERCP pancreatitis (OR 1.13: 95% CI [0.88, 1.46]). Subsequent sensitivity and subgroup analyses according to different criteria all confirmed these results.
CONCLUSIONS: Based on available evidence, prophylactic corticosteroids do not reduce the incidence of post-ERCP pancreatitis. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765955     DOI: 10.1159/000151999

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  7 in total

1.  Prophylaxis of pancreatitis with intravenous ketoprofen in a consecutive population of ERCP patients: a randomized double-blind placebo-controlled trial.

Authors:  Fernanda de Quadros Onófrio; Julio Carlos Pereira Lima; Guilherme Watte; Romnei Lenon Lehmen; Daniela Oba; Gabriela Camargo; Carlos Eduardo Oliveira Dos Santos
Journal:  Surg Endosc       Date:  2016-09-20       Impact factor: 4.584

2.  Preventive effect of tacrolimus on patients with post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Harshavardhan Rao B; Paul K Vincent; Priya Nair; Anoop K Koshy; Rama P Venu
Journal:  Clin Endosc       Date:  2022-08-02

Review 3.  Prevention of post-ERCP pancreatitis.

Authors:  Jennifer Maranki; Paul Yeaton
Journal:  Curr Gastroenterol Rep       Date:  2013-11

Review 4.  Prevention of post-ERCP pancreatitis.

Authors:  Lin-Lee Wong; Her-Hsin Tsai
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

Review 5.  Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis.

Authors:  Hiroki Yuhara; Masami Ogawa; Yoshiaki Kawaguchi; Muneki Igarashi; Tooru Shimosegawa; Tetsuya Mine
Journal:  J Gastroenterol       Date:  2013-05-30       Impact factor: 7.527

6.  Evaluation of N-acetyl Cysteine for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Double Blind Randomized Pilot Study.

Authors:  Pezhman Alavi Nejad; Eskandar Hajiani; Jalal Hashemi; Abdol Rahim Masjedizadeh; Ali Akbar Shayesteh; Vahid Sebghatollahi
Journal:  Middle East J Dig Dis       Date:  2013-01

7.  Chronic Use of Statins and Their Effect on Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.

Authors:  Mahmud Mahamid; Abdulla Watad; Nicola L Bragazzi; Dov Wengrower; Julie Wolff; Dan Livovsky; Howard Amital; Mohammad Adawi; Eran Goldin
Journal:  Front Pharmacol       Date:  2018-06-29       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.